PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Biochem Biophys Res Commun. Author manuscript; available in PMC 2010 November 27.
Published in final edited form as:
PMCID: PMC2763434
NIHMSID: NIHMS149244

Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-β

Abstract

Vascular endothelial cells respond to biomechanical forces, such as cyclic stretch and shear stress, by altering gene expression. Since endothelial-derived prostanoids, such as prostacyclin and thromboxane A2, are key mediators of endothelial function, we investigated the effects of cyclic stretch on the expression of genes in human umbilical vein endothelial cells controlling prostanoid synthesis: cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), prostacyclin synthase (PGIS) and thromboxane A2 synthase (TXAS). COX-2 and TXAS mRNAs were upregulated by cyclic stretch for 24 hours. In contrast, PGIS mRNA was decreased and stretch had no effect on COX-1 mRNA expression. We further show that stretch-induced upregulation of COX-2 is mediated by activation of the NF-κB signaling pathway.

Keywords: cyclic stretch, COX-1, COX-2, prostacyclin synthase, thromboxane synthase, endothelial cells, nuclear factor kappa B

Introduction

Prostacyclin (PGI2) and thromboxane A2 (TXA2) are the two most important prostanoids modulating vascular thromboresistance [5]. PGI2 is predominantly produced by endothelial cells and has potent anti-inflammatory, antiplatelet, anti-proliferative and vasodilatory effects [2]. TXA2 is mainly produced by activated platelets where it promotes aggregation during thrombus formation. Recent evidence reveals that TXA2 is also produced in endothelial cells where it promotes vasoconstriction as well as potentiating local platelet activation [12]. The balance between endothelial PGI2 and TXA2 generation is thought to regulate a wide array of vascular processes including vasomotor tone, inflammation, atherogenesis as well as thromboresistance [3;15].

The rate limiting step in PGI2 and TXA2 generation is metabolism of arachidonic acid to the prostaglandin intermediary H2 (PGH2) by the actions of the cyclooxygenase enzymes COX-1 and COX-2 [5]. PGH2 is subsequently converted to PGI2 and TXA2 by the actions of prostacyclin synthase (PGIS) and thromboxane synthase (TXAS), respectively. The COX-1 isoform is constitutively expressed in endothelial cells while the COX-2 isoform is induced by several number of physiologic stimuli, the best characterized being inflammation [5;21].

Vascular endothelial cells are exposed to a range of hemodynamic forces which can be markedly altered as consequence of cardiovascular disease. It is known that laminar shear stress is able to stimulate COX-1, COX-2 and PGIS expression in endothelial cells [6;13]. In contrast, the effects of cyclic stretch on endothelial prostenoid generation are largely unknown. To better understand how stretch regulates the balance in prostenoid production in endothelial cells, we explored the differential effects of cyclic stretch on the expression of genes involved in PGI2 and TXA2 generation. We further investigated the mechanism by which stretch regulates COX-2 induction.

Materials and Methods

Cell culture and materials

Human umbilical endothelial cells (HUVECs;American Type Culture Collection CRL-1730, Manassas, VA) were maintained in EGM-2 media (Lonza Inc., Allendate, NJ) under 5% CO2 at 37 °C. Cells of passages 2 to 5 were used for all experiments. All other chemicals were purchased from Sigma-Aldrich (St. Luis, MO) unless otherwise indicated.

In vitro stretch experiments

HUVECs were cultured onto type I collagen-coated 6-well Bioflex plates (Flexcell International, Hillsborough, NC). When nearly confluent, cells were subjected to 0–10% biaxial cyclic stain delivered at 1 Hz for the indicated times at 37 °C and 5% CO2 using an FX-4000T Tension Plus System (Flexcell International) as previously [7]. Pharmacological agents were added into cell media two hours before initiation of cyclic strain as indicated.

Real-time quantitative PCR

Total RNA was extracted from HUVECs using RNeasy Mini kit (Qiagen, Valenia, CA). After the treatment with DNase (Qiagen), RNA samples were subjected to reverse transcription (37 °C for 2 hours) using High Capacity cDNA reverse transcription kits (Applied Biosystems, Foster City, CA). Real-time PCR was performed with a 7900HT Sequence Detection System (Applied Biosystems) using TaqMan® Universal PCR Master Mix with specific probe and primers sets for each target gene purchased from Applied Biosystems (Human COX1: Hs00924803, COX2: Hs00153133_m1, TXAS: Hs0023423_m1, PGIS: Hs00168766_m1). mRNA expression of target gene was normalized to 18S ribosomal RNA (rRNA, Endogenous control (#4308329; Applied Biosystems).

Western blot analysis

Western blotting was performed using primary antibodies to human COX2 (#438933; Abcam, Cambridge, MA), and beta-actin (#A5441; Sigma-Aldrich) as previously described [7;17]. Protein expression level was normalized to beta-actin.

Quantification of nuclear factor kappa B (NF-kB) Activation. NF-kB activation was measured by an ELISA-based method (Trans-AM NF-kB p65; Active Motif) as previously described [17].

Statistic analysis

All data are presented as the mean ± SEM. Comparison between 2 groups is by 2-tailed t tests and between multiple groups is by one factor ANOVA followed by a Tukey’s multiple comparison test for intergroup comparisons. Only P values <0.05, considered to be statistically significant, are shown.

Results

Effect of cyclic stretch on COX gene expression

We first investigated the effects of cyclic stretch (0–10%, delivered at 1 Hz for 24 hours) on the expression of COX-1 and COX-2 mRNA expression in HUVECs. While COX-1 expression was not altered by cyclic stretch, levels of COX-2 mRNA proportionally increased in response to increasing cyclic stretch (Figure 1A). In similar fashion, levels of COX-2 protein similarly increased in response to stretch (Figure 1B). Time course studies revealed that cyclic stretch caused a marked induction in COX-2 mRNA (>2.5 that of control) within 3 hours of initiation of cyclic stretch stimuli that persisted for at least 24 hours, the duration of the experiment (Figure 1C).

Figure 1
Effects of cyclic stretch on COX mRNA expression. HUVECs were subjected to the indicated degree of cyclic stretch at 1 Hz for 24 hours. A) The mRNA levels of COX-1 and COX-2 were measured by quantitative PCR (n=6) * p<0.05, ** p<0.001 ...

COX-2 induction by cyclic stretch is mediated by activation of NF-κB

We next investigated the molecular mechanism by which cyclic stretch upregulates COX2 mRNA expression. Cyclic stretch did not alter the decay in levels of mRNA following treatment with actinomycin D (Figure 2A), indicating no change in mRNA stability. Pretreatment of HUVECs with cycloheximide also did not inhibit stretch-induced COX-2 mRNA upregulation (Figure 2B), indicating that new protein synthesis is not required. Given that nuclear factor-kappa beta (NF-kB signaling has recently been recognized as an important modulator of COX-2 gene expression [10;11;20], we investigated whether NF-kB signaling mediates COX-2 mRNA up-regulation by cyclic stretch. Treatment of HUVECs with parthenolide, a soluble sesquiterpene lactone inhibitor of NF-kB activation, prevented both stretch-induced NF-kB activation (Figure 2C left panel) and COX-2 mRNA upregulation (Figure 2C right panel), indicating that cyclic stretch stimulates COX-2 mRNA expression via a mechanism that is dependent on NF-kB signaling.

Figure 2
Mechanism of COX-2 mRNA upregulation. A) Stretch does not alter COX-2 mRNA stability. HUVECs were subjected to cyclic stretch (10%, 1 Hz) for 2 hours and then treated with actinomycin D (AcD, 10 g/ml) with cyclic stretch (0 or 10%, 1 Hz) for additional ...

Effects of cyclic stretch on PGIS and TXAS expression

Finally, we investigated the effects of cyclic stretch on mRNA expression of key downstream enzymes that mediate generation of prostacyclin and thromboxane A2. Cyclic stretch decreased the expression of prostacyclin synthase mRNA but increased the expression of thromboxane synthase mRNA (Figure 3), suggesting that it is capable of altering the balance of prostanoid production in human vascular endothelial cells.

Figure 3
Effects of cyclic stretch on PGIS and TXAS expression. HUVECs were subjected to cyclic stretch at 1 Hz for 24 hours and changes in mRNA levels of PGIS and TXAS measured by quantitative PCR (n=6). ** p<0.001 vs 0% stretch control.

Discussion

The major findings of this study are: (1) cyclic stretch stimulates COX-2 and TXAS mRNA expression, does not alter COX-1 mRNA expression and inhibits PGIS mRNA expression in human umbilical vein endothelial cells, and; 2) COX-2 upregulation by stretch is mediated via an NF-kB-dependent signaling pathway.

Cyclic stretch is a known modulator of prostenoid generation in a number of non-endothelial cell types. For example, stretch stimulates PGI2 production in fetal lung epithelial cells and both PGI2 and TXA2 production in uterine myometrial cells [4;9]. Stretch also upregulates the expression of the COX-2 gene in lung fibroblasts, patellar tendon fibroblasts and both bladder epithelial and smooth muscle cells [1;8;14;18;22]. Relevant to the current study, cyclic stretch has been previously been reported to upregulate both COX-2 and PGIs gene expression in bovine endothelial cells [16;19] While our data confirms the ability of stretch to upregulate COX-2 in human umbilical vein endothelial cells, we found that it downregulated PGIS mRNA expression. This raises the possibility that there may be differences in stretch responsiveness between endothelial cell subtypes. Our data also extends previous findings by demonstrating that cyclic stretch stimulates TXAS mRNA expression. This raises the possibility that stretch can alter the balance between endogenous PGI2 and TXA2 in vascular endothelial cells.

The most significant of our findings was that stretch-induced upregulation of COX-2 mRNA expression was mediated by activation of the NF-κB signaling pathway. NF-κB is known to mediate the upregulation of the COX-2 gene in response to stimulation with the inflammatory cytokines tumor necrosis factor-α and interleukin-1β as well as by thrombin [10;20]. Stretch-induced COX-2 upregulation in amnion cells has also been recently reported to be mediated by activation of NF-κB [11]. Our results reinforce the concept that NF-κB is a major regulator of COX-2 induction in multiple cell types by a variety of physiologic stimuli. Further studies will determine if the upregulation of TXAS by stretch is also mediated by NF-κB and whether this leads toalterations in the relative amounts of PGI2 and TXA2 by endothelial cells.

Acknowledgments

This work was supported by grants from National Institutes of Health HL080142 (to JJR) and HL07227 (to TH).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Adam RM, Eaton SH, Estrada C, Nimgaonkar A, Shih SC, Smith LE, Kohane IS, Bagli D, Freeman MR. Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells. Physiol Genomics. 2004;20:36–44. [PubMed]
2. Arehart E, Gleim S, Kasza Z, Fetalvero KM, Martin KA, Hwa J. Prostacyclin, atherothrombosis, and cardiovascular disease. Curr Med Chem. 2007;14:2161–2169. [PubMed]
3. Bunting S, Moncada S, Vane JR. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull. 1983;39:271–276. [PubMed]
4. Copland IB, Reynaud D, Pace-Asciak C, Post M. Mechanotransduction of stretch-induced prostanoid release by fetal lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;291:L487–L495. [PubMed]
5. Iniguez MA, Cacheiro-Llaguno C, Cuesta N, Diaz-Munoz MD, Fresno M. Prostanoid function and cardiovascular disease. Arch Physiol Biochem. 2008;114:201–209. [PubMed]
6. Inoue H, Taba Y, Miwa Y, Yokota C, Miyagi M, Sasaguri T. Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2002;22:1415–1420. [PubMed]
7. Kapur NK, Deming CB, Kapur S, Bian C, Champion HC, Donahue JK, Kass DA, Rade JJ. Hemodynamic modulation of endocardial thromboresistance. Circulation. 2007;115:67–75. [PubMed]
8. Kato T, Ishiguro N, Iwata H, Kojima T, Ito T, Naruse K. Up-regulation of COX2 expression by uni-axial cyclic stretch in human lung fibroblast cells. Biochem Biophys Res Commun. 1998;244:615–619. [PubMed]
9. Korita D, Sagawa N, Itoh H, Yura S, Yoshida M, Kakui K, Takemura M, Yokoyama C, Tanabe T, Fujii S. Cyclic mechanical stretch augments prostacyclin production in cultured human uterine myometrial cells from pregnant women: possible involvement of up-regulation of prostacyclin synthase expression. J Clin Endocrinol Metab. 2002;87:5209–5219. [PubMed]
10. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol. 2005;289:C1229–C1239. [PubMed]
11. Mohan AR, Sooranna SR, Lindstrom TM, Johnson MR, Bennett PR. The effect of mechanical stretch on cyclooxygenase type 2 expression and activator protein-1 and nuclear factor-kappaB activity in human amnion cells. Endocrinology. 2007;148:1850–1857. [PubMed]
12. Ogletree ML. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc. 1987;46:133–138. [PubMed]
13. Okahara K, Sun B, Kambayashi J. Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18:1922–1926. [PubMed]
14. Park JM, Yang T, Arend LJ, Schnermann JB, Peters CA, Freeman MR, Briggs JP. Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am J Physiol. 1999;276:F129–F136. [PubMed]
15. Reiss AB, Edelman SD. Recent insights into the role of prostanoids in atherosclerotic vascular disease. Curr Vasc Pharmacol. 2006;4:395–408. [PubMed]
16. Segurola RJ, Jr, Oluwole B, Mills I, Yokoyama C, Tanabe T, Kito H, Nakajima N, Sumpio BE. Cyclic strain is a weak inducer of prostacyclin synthase expression in bovine aortic endothelial cells. J Surg Res. 1997;69:135–138. [PubMed]
17. Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, Gardner K, Rade JJ. Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated via activation of nuclear factor-kappa B. Blood. 2005;105:3910–3917. [PubMed]
18. Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR, Johnson MR. Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod. 2004;10:109–113. [PubMed]
19. Sumpio BE, Banes AJ. Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery. 1988;104:383–389. [PubMed]
20. Syeda F, Grosjean J, Houliston RA, Keogh RJ, Carter TD, Paleolog E, Wheeler-Jones CP. Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. J Biol Chem. 2006;281:11792–11804. [PubMed]
21. Vanhoutte PM. COX-1 and vascular disease. Clin Pharmacol Ther. 2009;86:212–215. [PubMed]
22. Yang G, Im HJ, Wang JH. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene. 2005;363:166–172. [PMC free article] [PubMed]